U.S., Feb. 13 -- ClinicalTrials.gov registry received information related to the study (NCT06822712) titled 'Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for De Novo Coronary Bifurcation Lesions' on Feb. 06.
Brief Summary: Evaluating the Safety and Efficacy of Sirolimus-coated Coronary Balloon Dilatation Catheter vs Paclitaxel-coated balloon catheter for the Treatment of De Novo Coronary Bifurcation Lesions
Study Start Date: Feb., 2025
Study Type: INTERVENTIONAL
Condition:
Coronary Arterial Disease (CAD)
Intervention:
DEVICE: Sirolimus-coated Balloon Dilatation Catheter
During PCI, percutaneous transluminal coronary angioplasty is performed on the target lesion using the Sirolimus-coated Balloon Dilat...